SNOA - Sonoma Pharmaceuticals Launches in Major UK Pharmacy Chain after Securing UK Registration for Acne Products

2025-04-23 07:16:48 ET

DENVER, Colo., Apr 23, 2025 ( 247marketnews.com )- Sonoma Pharmaceuticals (NASDAQ:SNOA) reported the successful registration of its HOCl-based acne products with the U.K.’s Medicines & Healthcare products Regulatory Agency (MHRA). The registration paves the way for the launch of these products across more than 1,200 stores of a leading U.K. health and beauty retailer and pharmacy chain, marking a significant expansion for Sonoma in the dermatological market.

Amy Trombly, Sonoma’s CEO, stated, “We are excited to bring our safe and effective acne line to consumers in the United Kingdom and to expand our range of distribution in Europe. These products utilize all-natural hypochlorous acid and our patented Microcyn technology formulation, providing a safe and gentle alternative to products containing harsh ingredients such as alcohol and benzoyl peroxide.”

The new product line, featuring an acne toner and a balancing serum, will be sold under the retailer’s private label, broadening Sonoma’s footprint in the U.K. These products, designed to address acne and related skin conditions, build on Sonoma’s expertise in HOCl applications across wound care, eye, oral, nasal care, podiatry, and animal health.

The post Sonoma Pharmaceuticals Launches in Major UK Pharmacy Chain after Securing UK Registration for Acne Products appeared first on 24/7 MarketNews .

For further details see: